1:35 PM
 | 
Feb 24, 2017
 |  BC Week In Review  |  Financial News  |  Completed Offerings

TxCell completes private placement

On Feb. 22, immunotherapy company TxCell S.A. (Euronext:TXCL) raised €11 million ($11.7 million) through the sale of 5.5...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >